Complex Bioengineering for Cell Therapies Summit
The Complex Bioengineering for Cell Therapies Summit is your chance to tackle core challenges like safety, in vivo persistence, and payload delivery in next-gen treatments for solid tumors!
Learn more in the full program - https://ter.li/3mq13e
What’s in store:
-
Connect with leading molecular biologists to explore collaborations and innovative approaches
-
Discuss logic-gated therapies, payload capacity, and delivery techniques to shape the future of cell therapy
-
Focus on the latest in safety and persistence improvements for more effective treatments
Meet the Trailblazers
-
Gary Shapiro, Vice President, Discovery Biology, Affini-T Therapeutics
-
Cheng Liu, Chief Executive Officer, Eureka Therapeutics
-
Elena Peletskaya, Senior Director, Portfolio Technical Strategy, Bristol Myers Squibb
-
Salman Punekar, Assistant Professor, Perlmutter Cancer Center
-
John Rossi, Vice President, Translational Medicine, Capstan Therapeutics
-
Nicholas Frankel, Associate Director, Gene Circuit Discovery, Senti Biosciences
-
Henri Bayle, Chief Scientific Officer, NKILT Therapeutics
Download the full program – https://ter.li/3mq13e
Don’t miss this rare opportunity to connect with like-minded, on-the-ground professionals who are shaping the future of cell therapies for solid tumors.
